Cedazuridine (Standard)
Cedazuridine (Standard) is the analytical standard of Cedazuridine. This product is intended for research and analytical applications. Cedazuridine (E7727) (Compound 7a) is an orally active cytidine deaminase (CDA) inhibitor with an IC50 value of 0.4 μM. Cedazuridine can be used for cancer research[1].
Product Specifications
CAS Number
1141397-80-9
UNSPSC
12352100
Target
Others; Reference Standards
Related Pathways
Others
Field of Research
Cancer
Smiles
O[C@H]1C(F)(F)[C@H](N(CC[C@@H](O)N2)C2=O)O[C@@H]1CO
Molecular Formula
C9H14F2N2O5
Molecular Weight
268.21
References & Citations
[1]Ferraris D, et al. Design, synthesis, and pharmacological evaluation of fluorinated tetrahydrouridine derivatives as inhibitors of cytidine deaminase. J Med Chem. 2014 Mar 27; 57 (6) :2582-8.|[2]Ramsey H E, et al. Oral azacitidine and cedazuridine approximate parenteral azacitidine efficacy in murine model. Targeted Oncology, 2020, 15 (2) : 231-240.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSM041405-01 10 µg
Recombinant Mouse VEGF Receptor 2/VEGF R2/FLK-1/KDR (C-Fc)
Sign In for Pricing
View Details PKSM041405-02 50 µg
Recombinant Mouse VEGF Receptor 2/VEGF R2/FLK-1/KDR (C-Fc)
Sign In for Pricing
View Details 
